recommendation of selection of areas of highest vascularity or 'hot spots' in which to perform microvessel counts. This is based on the rationale that it is the highly angiogenic tumour cell clones that are most likely to behave aggressively and to metastasize (Weidner et al, 1992; Vermeulen et al, 1996) . A transverse tumour section has been found to be representative of whole tumour when microvessel counts in vascular 'hot spots' were compared with radiological grades from micro-angiographic assessments of the same tumours (Martin et al, 1997b) . However, another study addressing similar issues found noteworthy heterogeneity of microvessel counts between different areas of the same tumour and emphasized the need for careful 'hot spot' selection (de Jong et al, 1995) . Attempts have been made to improve objectivity of the counting method with use of a Chalkley eyepiece graticule or computerized image analysis (Fox et al, 1995) .
As an increasing number of patients undergo primary systemic treatment prior to tumour excision, the only specimen available for studies of potentially useful prognostic and predictive markers are core needle biopsies. Such core biopsies provide useful histological information (Minkowitz et al, 1986 ), but such material may not be representative of overall tumour vascularity (Jacobs et al, 1998) . In addition, effects of previous surgical manipulations on tumour vascularity assessment have not been addressed.
The aims of the present study were: (i) to assess intra-observer and inter-observer variation in microvessel counts; (ii) to determine whether core biopsies are representative of whole tumour; (iii) to investigate effects of previous surgical manipulation on subsequent biopsies.
MATERIALS AND METHODS

Patient material
Core biopsies Biopsies were performed following infiltration of the area with 20 ml 1% lignocaine with 1:200 000 adrenaline via a single stab incision at a point lateral to the lesion. Between one and seven biopsies were performed using a Pro-Mag gun and 14-gauge needle.
Tumour sections
Immediately following surgical excision, complete transverse sections of tumour were collected, including central and peripheral tumour areas.
Reproducibility of microvessel counts in breast cancer specimens
Study design
Three comparative studies were performed:
1. In 16 excised tumours, core biopsies were taken and tumour sections obtained at the same time. This allowed direct comparison of counts performed on core biopsies and sections taken simultaneously. 2. Twenty-one patients with newly diagnosed breast cancer underwent core biopsies for confirmation of diagnosis and determination of oestrogen receptor status. Following surgical excision of tumour between 5 and 35 days later, transverse tumour sections were collected. This allowed comparison of counts performed on core biopsies and tumour sections taken at a later time with no intervening treatment. 3. In ten cases, core biopsies were performed at diagnosis and repeated immediately following surgical excision, between 5 and 25 days later, thus allowing comparison of counts on core biopsies from the same tumour taken at different times.
Tumour preparation
All specimens were fixed in formalin for a minimum period of 24 h and paraffin-embedded. Four-micrometre sections were cut and a section of each sample stained with haematoxylin and eosin for histological assessment.
Immunohistochemistry
Immunohistochemistry was performed following antigen retrieval with protease using anti-CD31 antibody (Dako) (Parums et al, 1990) . The alkaline phosphatase anti-alkaline phosphatase (APAAP) technique was used to visualize antibody binding (Cordell et al, 1984) .
Microvessel counts
Following staining with CD31 the three areas of highest vascularity were identified by scanning sections at low power (×40 and ×100). Counts were performed at high power (×250) using a
Chalkley 25-point eyepiece graticule. In these areas, the graticule was oriented so that the maximum number of points lay on or within areas of highlighted vessels. Microvessel count (mvc) was taken as the total of three counts. All counts were performed using a conference microscope with two observers, a pathologist (KK) and a surgeon (LM) who had undergone a period of training in the technique. In addition, the individual investigators performed separate counts on 16 tumours to assess interobserver variability and together repeated counts on 31 tumours at different times to assess intra-observer variation.
Statistical analysis
Comparisons of pairs were made using Wilcoxon rank test. An expression of variation was calculated for intra-and inter-observer variation, as the standard deviation of the difference between two groups/mean of total. Correlations were determined using the Spearman rank correlation test.
RESULTS
Intra-and inter-observer variation
Microvessel counts performed by the same observers on two occasions (mvc1 and mvc2) at least a fortnight apart were compared in 31 tumours, of which 16 were core biopsies. Correlation between counts is illustrated in Figure 1 . Mvc1 ranged from 12 to 28 (median: 16, mean: 16.4) and mvc2 from 14 to 28 (median: 17, mean: 17.7). There was significant correlation between the two counts (r = 0.84, P < 0.001). The standard deviation of difference between the two groups was 1.95, giving an expression of variation of 11%. counts of the two observers (r = 0.83, P < 0.001). The standard deviation of differences was 3.03, giving an expression of variation of 15%.
Comparison between mvc of core biopsies and tumour cross-section from excised tumours
Core biopsies were taken of 16 tumours immediately following surgical excision. The number of core biopsies taken from each tumour ranged from 1 to 7 (median: 3, mean: 3.3). Figure 3 illustrates immunohistochemical staining of vessels with antibody to CD31 in a core biopsy section ( Figure 3A ) and tumour section ( Figure 3B ). Figure 4 illustrates the correlation between counts in cores and tumour sections. Mvc in core biopsies ranged from 13 to 22 (median: 17, mean: 16.5) and in tumour sections from 14 to 24 (median; 18, mean: 18). There was no significant difference in mvc between the two groups (P = 0.1, paired Wilcoxon). Conversely whilst there was a positive correlation in counts, this just failed to reach statistical significance (r = 0.44, P = 0.09). Mvc was higher in tumour sections than core biopsies in nine of 16 tumours (56%), was higher in core biopsies in three of 16 tumours (18.8%) and the same in four (25%).
Comparison between mvc of core biopsy and subsequent tumour cross-section
Core biopsies were taken for diagnosis in 21 patients who underwent surgery between 5 and 34 days later (median time to surgery: 23 days), with no intervening treatment. One patient was found to have carcinoma in situ with no evidence of invasion and was excluded from the study. The number of core biopsies taken ranged from 1 to 6 (median: 3, mean: 2.95). Transverse sections of the same tumours were taken at surgery. The relationship between counts of cores and subsequent tumour cross-sections is shown on Figure 5 . Microvessel counts in core biopsies ranged from 12 to 25 (median: 16, mean: 17.1) and in later tumour cross-sections from 15 to 25 (median: 21, mean: 21.1). Although the range of mvc values in cores and subsequently excised material was similar, there was no significant correlation between them (r = -0.1). There was a significant difference in counts in the two sample types with values tending to be higher in tumour sections than core biopsies (P = 0.0065, paired Wilcoxon). This was reflected in 13 of 20 tumours (65%) in which counts were higher in tumour sections than cores, in four of 20 tumours (20%) counts were higher in core biopsies and identical values were obtained in three tumours (15%).
Comparison between mvc of core biopsies at diagnosis and following surgical excision
Multiple core biopsies were taken of tumours in ten patients for diagnosis and were repeated immediately following surgical excision. The number of cores performed ranged from 1 to 7 (median: 3, mean: 3.05). Figure 6 illustrates the relationship between counts in cores at the two time points. Mvc in cores at diagnosis (mvc1) ranged from 10 to 22 (mean 16.4, median 16.5) and in cores at surgery (mvc2) ranged from 13 to 21 (mean: 17.4, median: 18). No significant association was found between counts in the pairs of cores (r = -0.38). Conversely, no significant difference in mvc was detected (P = 0.48), with counts being higher in later cores in five of 10 tumours (50%), higher in initial biopsies in four tumours (40%) and the same in one (10%).
Correlation between number of cores performed and Codifference in mvc between cores and tumour section
Analysis was performed to determine whether there was a relationship between number of cores performed and the difference in mvc between cores and tumour sections. In 37 cases, cores and tumour section were available for comparison. Number of cores performed ranged from 1 to 7 (median: 3, mean: 3.13). Mvc difference was expressed as a percentage of total mvc count in the tumour section, and its relationship with number of cores is illustrated on Figure 7 . No significant correlation was identified (r = -0.25, P > 0.05).
DISCUSSION
The present study has attempted to assess the variation in assessment of angiogenesis which might be caused by (i) inherent variation in the method, (ii) tumour heterogeneity and (iii) previous surgical manipulation of tumour.
Variation in mvc between the same observers performed at different times was 11% in this study, with a highly significant correlation between the two sets of counts (r = 0.84, P < 0.001). Inter-observer variation was 15%, which is comparable to another study addressing the same issue (Martin et al, 1997a) . The issues of observer variation have been raised in several studies as a possible reason for failure of angiogenesis assessment to provide useful prognostic information in some series of primary breast cancers (Van Hoef et al, 1993; Axelsson et al, 1995) . In both studies, mvc was used as a categorized rather than a continuous variable (Van Hoef et al, 1993; Axelsson et al, 1995) , which may result in loss of predictive power (Vermeulen et al, 1996) . Another study addressing the issue of observer variation found that mvc provided independent prognostic information in a series of breast tumours when performed by experienced observers, but not by the least experienced observer (Vermeulen et al, 1997) . The authors therefore recommended a period of training with an experienced observer (Vermeulen et al, 1997) . In the present study, counts were performed by two observers, a pathologist and a surgeon, who had undertaken a period of training with an experienced observer before embarking on the study. Other methods have been suggested to improve objectivity of the counting method, such as use of a Chalkley eyepiece graticule, as described in the present No. of cores % mvc difference
Figure 6
Relationship between mvc performed on core biopsies taken at separate time points, where mvc of cores 1 are counts on the first set of cores and mvc of cores 2 counts on the second set (Spearman rank correlation: r = 0.38, P = 0.48)
Figure 7
Percentage difference in mvc between two tumour samples versus number of cores taken (Spearman rank correlation: r = 0.25, P > 0.05) study, or computerized image analysis (Fox et al, 1995) . In a recently published study comparing inter-observer variability using different counting methods, use of the Chalkley grid yielded low variability and was found to be more effective in reducing variation than selection of the same hot spot by different observers (Hansen et al, 1998) . Reproducibility was further optimized by the use of a conference microscope, thereby eliminating subjectivity in hot spot selection and field sampling (Hansen et al, 1998) . The low degree of inter-observer variability observed in the present study is likely to be related to the use of the Chalkley grid by two observers using a conference microscope. Tumour heterogeneity in vasculature was investigated in the present study by comparing microvessel counts in core biopsies and tumour sections taken simultaneously. Whilst the range of counts was similar in the two groups, correlation between counts failed to reach statistical significant (r = 0.44, P = 0.09). Vessel counts in tumour sections tended to be higher than those in core biopsies. Heterogeneity of tumour vasculature between different areas of the same tumour is well-recognized (Weidner et al, 1991; Van Hoef et al, 1993) and is overcome to an extent by selection of three vascular 'hot spots'. Alternatives to the original method proposed by Weidner have been suggested and may particularly benefit the less experienced observer. These are to perform counts in ten fields of high vascularity, taking the highest count as the mvc (Martin et al, 1997a) , or to perform photomicrographs of the most intensely vascular areas and for individual observers to obtain counts from the photographs (Vermeulen et al, 1997) . Core biopsies represent only a small cross-section of total tumour and are therefore less likely to include individual vascular 'hot spots' than a larger tumour section. Indeed, in some core biopsy specimens it was difficult to clearly identify three hot spots. The differences in vessel density in 'hot spots' found in core biopsies and tumour sections are illustrated on Figure 3 , which clearly shows a lower density in the core biopsy compared with the tumour section. These observations were further borne out in the findings that counts in core biopsies were lower than those in tumour sections in 65% of tumours and higher in only 20%. Another study which addressed the role of core biopsies found a similar lack of correlation in mvc of cores and tumour sections, but found mvc to be higher in core biopsies than tumour sections in 61.2% of cases (Jacobs et al, 1998) .
Problems with tumour heterogeneity are not unique to vascular assessments, but have been described for several other parameters in breast cancer. Significant variations in mitotic activity index assessed on haematoxylin and eosin sections (Jannink et al, 1996) and DNA cell cycle variables (Bergers et al, 1996) were found on assessment of multiple tumour sections. Conversely, levels of MIB-1 and oestrogen receptor expression were found to alter little in assessments of serial tumour sections (Jensen and Ladekarl, 1995) .
The issue of the accuracy of core biopsies in providing prognostic information is important as such specimens are increasingly used in diagnosis and may provide the only pretreatment tissue available. Other studies have addressed similar issues for markers other than angiogenesis and reproducible results have been obtained for determinations of DNA ploidy, bcl-2, oestrogen receptor, c-erbB-2 and p53, which are dichotomously scored variables (Daidone et al, 1991; Jacobs et al, 1998) . Jacobs et al failed to produce reproducible results for mvc and accuracy was not improved by increasing tumour area available for assessment by performing more core biopsies (Jacobs et al, 1998) . This is in keeping with results from the present study, in which, whilst there is a suggestion from Figure 6 that difference in mvc may be reduced with an increasing number of core biopsies, this correlation failed to reach statistical significance.
Another possible reason for unreliability of sequential core biopsies in tumour vascular assessment is the likely induction of angiogenesis following initial biopsy as part of the normal process of wound healing (Folkman, 1971) . Comparison of mvc in core biopsies and subsequent tumour sections and in sequential core biopsies with no intervening treatment failed to show any correlation (Figures 4 and 5) , which may be due to inherent variability in vessels throughout the tumour and/or effects of previous surgical manipulation.
In summary, this study has addressed various practical issues regarding the methodology of tumour vascularity assessment by mvc. Intra-and inter-observer variation in counts were 11 and 15% respectively, which were similar to results of other studies. Tumour heterogeneity is a problem when adopting this method in small tumour biopsies, such as core biopsies, which may not contain vascular 'hot spots'. In addition, angiogenesis takes place in conditions other than tumour growth, such as wound healing and is therefore likely to be stimulated by surgical manipulation of the tumour, affecting subsequent assessments. Results of the present study suggest that mvc on core biopsy specimens are unlikely precisely to represent overall tumour vascularity. Other markers of angiogenesis, such as angiogenic growth factor expression, which may be assessed in tumour or serum, may provide an alternative method of assessment. These may be less subject to such variations, as the methods involved are not dependent on selection of specific tumour areas for assessment.
